| Ill | Not Ill | |
|---|---|---|
| Exposed | a | b |
| Unexposed | c | d |
Surveillance types:
Bar/histogram=epi curve, cases over time · Line graph=trend over time · Pie chart=proportions of a whole · Spot map=exact case locations · Area map=shades whole regions by rate · Scatter plot=correlation of two variables
SciOly steps: 1 Prepare · 2 Establish outbreak · 3 Verify diagnosis · 4 Define & identify cases · 5 Describe by time/place/person · 6 Develop hypotheses · 7 Evaluate hypotheses · 8 Refine hypotheses · 9 Control & surveillance · 10 Communicate findings
Descriptive (no comparison group):
Analytical (compares groups):
Experimental — researcher assigns exposure/treatment (e.g., RCT); strongest evidence for causation
Breaking any one link stops the chain — controls target the weakest link.
Portals of entry: mucous membranes, resp./GI tract, broken skin, parenteral. (Intact skin is a barrier, not a portal.)
Control by link: Agent—treat/disinfect · Reservoir—treat carriers · Portal of exit—cover, dispose safely · Transmission—sanitation, vector control · Portal of entry—PPE, safe prep · Host—vaccinate, prophylaxis
Basic Reproduction Number (R₀) — average number of secondary cases caused by one case in a fully susceptible population.
Herd immunity threshold State/Nats = 1 − 1/R₀: share who must be immune to stop spread (measles R₀≈15 → 93%).
Don't confuse: Vector=living (mosquito) · Fomite=object (doorknob) · Vehicle=substance (water, food)
Epidemiologist designs & analyzes; local/state health dept. is first responder; CDC assists on request (national surveillance/labs); laboratorian confirms pathogen; providers report & treat.
Line listing — a spreadsheet with one row per case & columns for key variables (person/place/time, exposures, symptoms); the working tool for spotting patterns during an investigation.
PFGE / PulseNet — DNA fingerprinting that compares pathogen strains from different patients; matching patterns confirm cases share a common source (not just a similar illness).
6 Core Functions of Epidemiology: Surveillance, Field investigation, Analytic studies, Evaluation, Linkages, Policy development.
5-Step Surveillance Process: Identify & define the problem → Collect data → Analyze & interpret → Disseminate findings → Evaluate & act (repeat).
Doesn't fit every pathogen: viruses need host cells to culture, some carriers show no symptoms, and some diseases have multiple/unclear causes.
Susceptibility → exposure → Subclinical disease (incubation/latency) → onset of symptoms → Clinical disease (usual time of diagnosis) → Recovery, disability or death
VE = 1 − RR, RR = ARvaccinated ÷ ARunvaccinated. 5% vs 25% ill → RR 0.2 → VE 80% ("80% lower risk"). Best design: RCT vs placebo; concern: ethics.
4 stages of control: Control=reduced to acceptable level, needs upkeep (active outbreaks). Elimination=zero in one area, exists elsewhere (polio). Eradication=zero worldwide — only smallpox (1980) & rinderpest (2011). Extinction=agent gone from nature and labs (none yet).
Danger zone: 40°F–140°F — bacteria multiply fastest; max 2 hr (1 hr above 90°F). Cook poultry to 165°F, ground beef 160°F. Toxins (Staph, B. cereus) survive reheating.
Humans are the only reservoir (no animal/environmental source) · an effective, long-lasting vaccine or cure exists · clinical signs are easy to recognize (little silent/subclinical spread) · a reliable diagnostic test exists. Smallpox met all four; malaria and polio still don't (animal/environmental reservoirs or silent spread).
Reservoirs: Human (case/carrier, e.g. typhoid) · Animal (zoonotic, e.g. rabies) · Environmental (soil/water, e.g. Legionella)
Agent types: Bacteria · Viruses · Fungi (e.g. ringworm) · Protozoa (e.g. malaria) · Prions (e.g. mad cow disease)
The study of the distribution & determinants of health-related events in populations, and applying that study to control health problems.
The 3 axes of descriptive epi — Person=who, Place=where, Time=when.
Built from clinical criteria (signs/symptoms), restrictions (person, place, time), and lab confirmation.
Confirmed = positive lab (even with no symptoms). Probable = typical symptoms, no lab yet. Possible/suspect = some symptoms, no lab. Not a case = lab shows a different agent, or criteria not met.
(1) Control/prevention · (2) Research opportunity · (3) Public, political, legal concerns · (4) Public health program considerations · (5) Training
Wrongly assuming a group-level (population) association applies to every individual within that group — a risk specific to ecological studies.
PFGE / PulseNet — DNA fingerprinting comparing pathogen strains between patients; a match confirms a shared source. SNP mapping — compares tiny single-letter DNA differences between pathogen samples; higher resolution than PFGE for linking cases.
Quarantine — restricts exposed, not-yet-sick people. Isolation — separates already confirmed/symptomatic people.
Infectious — caused by a transmissible pathogen (spreads person-to-person, vector, or vehicle). Non-infectious — caused by genetics, environment/toxins, or lifestyle (e.g., chemical exposure, diabetes) — cannot spread between people.
Clinical — diagnoses & treats one patient at a time (e.g., a family doctor). Public health — prevents & controls health issues across whole populations (e.g., a health inspector, vaccination campaigns, policy). A school nurse screening every student for lice does both at once.
Framingham Heart Study (1948–) — cohort; found heart-disease risk factors (BP, cholesterol, smoking).
British Doctors' Study (Doll & Hill, 1951) — cohort; smoking causes lung cancer → anti-smoking policy.
Salk polio trials (1954) — placebo-controlled field trial, 1.8M kids; vaccine works → mass vaccination.
Nurses' Health Study (1976–) — diet/lifestyle & chronic disease in women.
Whitehall Studies (1967–) — lower job rank, higher death rates → social determinants.
WHO Director-General: Tedros Adhanom Ghebreyesus. CDC Director: Erica Schwartz.